Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
Moodys
Dow
Mallinckrodt
Baxter

Last Updated: October 6, 2022

Xiromed Company Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the competitive landscape for XIROMED, and what generic and branded alternatives to XIROMED drugs are available?

XIROMED has thirty-four approved drugs.



Summary for Xiromed
US Patents:0
Tradenames:32
Ingredients:22
NDAs:34

Drugs and US Patents for Xiromed

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Xiromed SYEDA drospirenone; ethinyl estradiol TABLET;ORAL-28 090114-001 Mar 28, 2011 AB RX No No See Plans and Pricing See Plans and Pricing
Xiromed ACYCLOVIR acyclovir OINTMENT;TOPICAL 201501-001 Jan 29, 2020 AB RX No No See Plans and Pricing See Plans and Pricing
Xiromed FULVESTRANT fulvestrant INJECTABLE;INTRAMUSCULAR 213553-001 Aug 13, 2021 AO RX No No See Plans and Pricing See Plans and Pricing
Xiromed CLOBETASOL PROPIONATE clobetasol propionate OINTMENT;TOPICAL 209701-001 Apr 17, 2018 AB RX No No See Plans and Pricing See Plans and Pricing
Xiromed FLUOCINONIDE fluocinonide OINTMENT;TOPICAL 212976-001 Nov 26, 2019 AB RX No No See Plans and Pricing See Plans and Pricing
Xiromed VOLNEA desogestrel; ethinyl estradiol TABLET;ORAL-28 202689-001 Sep 9, 2016 AB RX No No See Plans and Pricing See Plans and Pricing
Xiromed LORYNA drospirenone; ethinyl estradiol TABLET;ORAL 079221-001 Mar 28, 2011 AB RX No No See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for XIROMED drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
Moodys
Harvard Business School
Medtronic
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.